NCT04302142

Brief Summary

The purpose of the study is to achieve effective ventilation with critical intracuff pressure (Pcr) and determine if application of Pcr reduces the risks associated with over-insufflation of endotracheal cuff including postoperative sore throat, cough,nausea, vomiting, aspiration, and pneumonia.

Trial Health

30
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Jun 2021

Geographic Reach
1 country

1 active site

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 6, 2020

Completed
4 days until next milestone

First Posted

Study publicly available on registry

March 10, 2020

Completed
1.2 years until next milestone

Study Start

First participant enrolled

June 1, 2021

Completed
Same day until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2021

Completed
Last Updated

September 1, 2022

Status Verified

August 1, 2022

Enrollment Period

Same day

First QC Date

March 6, 2020

Last Update Submit

August 26, 2022

Conditions

Keywords

anesthesiaendotracheal tube cuff pressure

Outcome Measures

Primary Outcomes (1)

  • Minimum intracuff pressure at which there is no air leak around the cuff.

    during surgery

Secondary Outcomes (12)

  • Number of patients with postoperative sore throat as measured by a standardized questionnaire

    30 minutes post extubation

  • Number of patients with postoperative sore throat as measured by a standardized questionnaire

    2 hours post extubation

  • Number of patients with postoperative sore throat as measured by a standardized questionnaire

    24 hours post extubation

  • Number of patients with postoperative coughing as measured by a standardized questionnaire

    30 minutes post extubation

  • Number of patients with postoperative coughing as measured by a standardized questionnaire

    2 hours post extubation

  • +7 more secondary outcomes

Study Arms (2)

Intervention group

EXPERIMENTAL
Device: ventilation with critical intracuff pressure (Pcr)

Control Group

PLACEBO COMPARATOR
Device: ventilation with critical intracuff pressure (Pcr)

Interventions

Once the intra-cuff pressure is measured and recorded, the cuff will be deflated by drawing the air 0.5ml per step with each step lasting 3 breaths until a leak, in which a 10% reduction in expiratory volume over the inspiratory tidal volume, is detected.Cuff will then be reinflated until the expiratory tidal volume reaches the inspiratory tidal volume and the discrepancy between the inspiratory and expiratory tidal volume is less than 10 percent. If the intra-cuff pressure applied by the anesthesia care team is inadequate and the discrepancy between the inspiratory and expiratory tidal volume is 10% or greater, the cuff will be further inflated with air 0.5ml per step with each step lasting 3 breaths until it reaches Pcr. This Pcr will be maintained during the entire anesthesia time until extubation.During the course of surgery, if any leak is detected, the cuff will be re-inflated by 0.5ml of air until the leak is not detectable.

Intervention group

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Elective Surgery under general anesthesia requiring endotracheal tube with mechanical ventilation and expected anesthesia duration of at least 2 hours.
  • No contra-indication for intra-operative volume controlled mechanical ventilation
  • Flat supine surgeries without expected positional adjustments
  • American Society of Anesthesiologists (ASA) physical status I-III

You may not qualify if:

  • Use of Nitrous Oxide
  • BMI \> 40
  • Ventilation through Nasal intubation or Tracheostomy
  • Preexisting sore throat, coughing, nausea/vomiting
  • Recent history of upper respiratory infection
  • Pregnancy
  • Expected to be kept intubated after surgery completion

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The University of Texas Health Science Center at Houston

Houston, Texas, 77030, United States

Location

MeSH Terms

Interventions

Polymerase Chain Reaction

Intervention Hierarchy (Ancestors)

Nucleic Acid Amplification TechniquesGenetic TechniquesInvestigative Techniques

Study Officials

  • Yandong Jiang, MD,PhD

    The University of Texas Health Science Center, Houston

    PRINCIPAL INVESTIGATOR
0

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, CARE PROVIDER
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Visiting Professor

Study Record Dates

First Submitted

March 6, 2020

First Posted

March 10, 2020

Study Start

June 1, 2021

Primary Completion

June 1, 2021

Study Completion

June 1, 2021

Last Updated

September 1, 2022

Record last verified: 2022-08

Data Sharing

IPD Sharing
Will not share

Locations